KEY WEST, Fla. BPC-157 is attracting interest as researchers explore its potential to help the body heal after injury. A newly released federal peptide compounding policy is adding to the discussion about future options for nonsurgical orthopedic care at Key West Concierge Orthopedics.

The draft policy released by the U.S. Department of Health and Human Services on October 28, 2026, outlines conditions for licensed pharmacies to prepare certain peptides for individual patients with a physician's prescription. Compounding means preparing a medication for an individual patient's needs. The policy emphasizes ingredient testing, documented sourcing, and safety reporting, potentially supporting a more structured approach to patient access. [1]

Peptides are short chains of amino acids, the building blocks of proteins. Researchers are studying whether BPC-157 can support the body's repair processes, particularly those involved in tendon and muscle recovery.

Early animal research offers encouraging clues. In one rat study, treatment after an Achilles tendon injury improved tendon strength and the organization of collagen. Collagen gives tendons their structure and helps them withstand the forces of movement. Researchers measured how much force the healing tendon could tolerate, providing information about the quality of repair beyond its appearance. [2]

Laboratory research using rat tendon cells also found improved cell movement and survival under challenging conditions. These cells help maintain the material that forms a tendon. Their ability to survive and move is part of the repair process, making these findings useful starting points for further investigation. [3]

Other animal research found better blood flow and more small blood vessels in muscle with poor circulation. Blood vessels carry oxygen and nutrients to tissue, making this another area of interest for researchers studying recovery. Understanding these effects could help researchers explore how to support injured tissue while rehabilitation rebuilds strength and movement. [4]

If these early findings translate into benefits for people, BPC-157 could eventually become an additional option alongside physical therapy and other nonsurgical treatments. The hope is to support tissue repair, improve function, and help patients recover strength and movement after injury. Human studies can examine whether those possibilities produce meaningful improvements in daily function and return to activity.

These compounded products are not FDA-approved, and more studies in people are needed to establish their benefits and safety. Continued research can help show whether these promising findings will lead to useful treatments. [1]

Patients are encouraged to bring questions, a current medication list, and information about specific treatments they have already tried. That preparation can make a consultation more useful and personal. It also helps the physician explain how any proposed option fits into the patient's broader care, including activity, rehabilitation, and ongoing medical conditions.

For our clinic, the encouraging development is the chance to pair interest in new options with individual medical assessment and clear information. Patients seeking updates or an evaluation of an orthopedic concern can contact Key West Concierge Orthopedics. Our priority is helping each person make an informed decision about care that supports an active life.

Sources

Medically reviewed by
Jason Pirozzolo, DO
Fellowship Trained and Board Certified in Sports Medicine
Certified Strength and Conditioning Specialist (CSCS)
Specializing in Non-Surgical Orthopedics and Image-Guided Joint Injections
Licensed Physician, State of Florida

Last medically reviewed: October 30, 2026
Dr. Jason Pirozzolo: full physician profile and credentials